9QDP | pdb_00009qdp

De novo designed enzyme for Morita-Baylis-Hillman reaction MBH2


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.17 Å
  • R-Value Free: 
    0.164 (Depositor), 0.164 (DCC) 
  • R-Value Work: 
    0.134 (Depositor), 0.134 (DCC) 
  • R-Value Observed: 
    0.136 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Computational enzyme design by catalytic motif scaffolding.

Braun, M.Tripp, A.Chakatok, M.Kaltenbrunner, S.Fischer, C.Stoll, D.Bijelic, A.Elaily, W.Totaro, M.G.Moser, M.Hoch, S.Y.Lechner, H.Rossi, F.Aleotti, M.Hall, M.Oberdorfer, G.

(2025) Nature 

  • DOI: https://doi.org/10.1038/s41586-025-09747-9
  • Primary Citation of Related Structures:  
    9FW5, 9FW7, 9FWA, 9GBT, 9QDP, 9R7F

  • PubMed Abstract: 

    Enzymes find broad use as biocatalysts in industry and medicine owing to their exquisite selectivity, efficiency and mild reaction conditions. Custom-designed enzymes can produce tailor-made biocatalysts with potential applications that extend beyond natural reactions. However, current design methods require testing a large number of designs and mostly produce de novo enzymes with low catalytic activities 1-3 . As a result, they require costly experimental optimization and high-throughput screening to be industrially viable 4,5 . Here we present rotamer inverted fragment finder-diffusion (Riff-Diff), a hybrid machine learning and atomistic modelling strategy for scaffolding catalytic arrays in de novo proteins. We highlight the general applicability of Riff-Diff by designing enzymes for two mechanistically distinct chemical transformations, the retro-aldol reaction and the Morita-Baylis-Hillman reaction. We show that in both cases, it is possible to generate catalysts that exhibit activities rivalling those optimized by in vitro evolution, along with exquisite stereoselectivity. High-resolution structures of six of the designs revealed near-atomic active site design precision. The design strategy can, in principle, be applied to any catalytically competent amino acid array. These findings lay the basis for practical applicability of de novo protein catalysts in synthesis and describe fundamental principles of protein design and enzyme catalysis.


  • Organizational Affiliation
    • Institute of Biochemistry, Graz University of Technology, Graz, Austria.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
De novo designed enzyme for Morita-Baylis-Hillman reaction MBH2221synthetic constructMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.17 Å
  • R-Value Free:  0.164 (Depositor), 0.164 (DCC) 
  • R-Value Work:  0.134 (Depositor), 0.134 (DCC) 
  • R-Value Observed: 0.136 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 56.775α = 90
b = 51.881β = 112.273
c = 72.606γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
autoPROCdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Austrian Science FundAustriaP30826

Revision History  (Full details and data files)

  • Version 1.0: 2025-12-10
    Type: Initial release